Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11687185rdf:typepubmed:Citationlld:pubmed
pubmed-article:11687185lifeskim:mentionsumls-concept:C0700589lld:lifeskim
pubmed-article:11687185lifeskim:mentionsumls-concept:C0009905lld:lifeskim
pubmed-article:11687185lifeskim:mentionsumls-concept:C0205184lld:lifeskim
pubmed-article:11687185pubmed:issue4lld:pubmed
pubmed-article:11687185pubmed:dateCreated2001-11-5lld:pubmed
pubmed-article:11687185pubmed:abstractTextSide effects caused by oral contraceptives discourage compliance with and continuation of oral contraceptives. A suggested disadvantage of biphasic oral contraceptive pills as compared to triphasic oral contraceptive pills is an increase in breakthrough bleeding. We conducted this systematic review to examine this potential disadvantage.lld:pubmed
pubmed-article:11687185pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11687185pubmed:languageenglld:pubmed
pubmed-article:11687185pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11687185pubmed:citationSubsetIMlld:pubmed
pubmed-article:11687185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11687185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11687185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11687185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11687185pubmed:statusMEDLINElld:pubmed
pubmed-article:11687185pubmed:issn1469-493Xlld:pubmed
pubmed-article:11687185pubmed:authorpubmed-author:GrimesDDlld:pubmed
pubmed-article:11687185pubmed:authorpubmed-author:SchulzKKlld:pubmed
pubmed-article:11687185pubmed:authorpubmed-author:HelmerhorstFFlld:pubmed
pubmed-article:11687185pubmed:authorpubmed-author:Van VlietHHlld:pubmed
pubmed-article:11687185pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11687185pubmed:ownerNLMlld:pubmed
pubmed-article:11687185pubmed:authorsCompleteYlld:pubmed
pubmed-article:11687185pubmed:paginationCD003283lld:pubmed
pubmed-article:11687185pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:meshHeadingpubmed-meshheading:11687185...lld:pubmed
pubmed-article:11687185pubmed:year2001lld:pubmed
pubmed-article:11687185pubmed:articleTitleBiphasic versus triphasic oral contraceptives for contraception.lld:pubmed
pubmed-article:11687185pubmed:affiliationFamily Health International, P. O. Box 13950, Research Triangle Park, North Carolina 27709, USA. dgrimes@fhi.orglld:pubmed
pubmed-article:11687185pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11687185pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11687185lld:pubmed